Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | DC AML Vaccine |
Trade Name | |
Synonyms | |
Drug Descriptions |
DC AML vaccine is generated by fusing patient derived AML cells with autologous dendritic cells, resulting in anti-tumor immune response (PMID: 25625926, Blood 2013 122:3928). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
DC AML Vaccine | DC AML Vaccine | 0 | 1 |
DC AML Vaccine + Durvalumab | DC AML Vaccine Durvalumab | 0 | 1 |